Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
about
Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma.Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patientsInterleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targetsHistologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.CD117 (KIT) is a useful marker in the diagnosis of plasmablastic plasma cell myeloma.Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.A rare case of Epstein-Barr virus-related plasmacytoma involving maxillary sinus mucosa.An immunocompetent patient with a recurrence-free EBV positive plasmacytoma possesses robust Epstein-Barr virus specific T cell responses.Prognostic value of parameters derived from white blood cell and differential counts in patients receiving palliative radiotherapy.Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review.Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue.Plasmablastic lymphoma in Malawi.EBV infection determines the immune hallmarks of plasmablastic lymphoma
P2860
Q36082530-8530358A-B0D7-4BE7-9950-D90D1BE2B580Q36984708-3B1C54FD-E726-437F-85D6-8829D3ED814FQ37140496-60142342-5B61-45DE-AFA3-0226D230B325Q38599063-0EA8C1F0-E372-4602-801E-4CAAE3A4E432Q38896306-55A3B69F-8C51-410A-9026-6BFDA75CEE8FQ38947975-1C8B1679-4DD0-46A7-9AEE-927E488F5F4CQ39052187-68F6621A-7015-425D-BE3E-2E4EF59CBC11Q39232108-BF96FBD6-0EDB-4140-AD3B-102A13308FE3Q39337417-7958407A-5009-49B9-AD59-03E70374100CQ40054661-AC0431CD-F6CE-4E22-BBD8-886D5D17CE0FQ40123520-F3BF4FD1-A20E-4352-8B87-DA10F0833C73Q41171241-63CE76AE-AFD1-403F-B230-C0A3922F7668Q42705888-B47FC907-5252-408D-ACBD-FB3FFD5C49C4Q50300672-6F819A2E-28DE-4019-888B-7B5B71930550Q55454606-42961370-D93B-4A72-A480-F556EA809B8AQ56968100-36AD71F8-F382-4401-ADB3-AF86ADD623B4
P2860
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@ast
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@en
type
label
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@ast
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@en
prefLabel
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@ast
Stage, age, and EBV status imp ...... logic analysis of 61 patients.
@en
P2093
P2860
P1476
Stage, age, and EBV status imp ...... ologic analysis of 61 patients
@en
P2093
C Cameron Yin
Guilin Tang
Joseph D Khoury
Khaled Alayed
L Jeffrey Medeiros
Roberto N Miranda
Sanam Loghavi
Tariq N Aladily
Zhuang Zuo
P2860
P2888
P356
10.1186/S13045-015-0163-Z
P50
P577
2015-06-10T00:00:00Z
P5875
P6179
1029036740